A Phase 2 Study of CRLX101(NLG207) in Patients With Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2014-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare median overall survival of patients with advanced
non-small cell lung cancer (NSCLC) treated with CRLX101 to patients treated with best
supportive care (BSC).